Mode
Text Size
Log in / Sign up
N/A N=184 Randomized Double-blind Treatment

Manual Therapy and Strengthening for the Hip in Older Adults With Chronic Low Back Pain

Chronic Low-back Pain · Hip Impairments · Hip-spine Syndrome · Osteoarthritis

Enrolled (actual)
184
Serious AEs
7.1%
Results posted
Apr 2024
Primary outcome: Primary: Quebec Back Pain Disability Scale — 27.9; 27.9; 16.7; 20.3 score on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Hip-focused rehabilitation intervention (Behavioral); Spine-focused rehabilitation intervention (Behavioral)
Age
Adult, Older Adult · 60+ yrs
Sex
All
Sponsor
University of Delaware
Primary completion
Oct 2022

Outcome Measures

OutcomeResultp-value
PRIMARY
Quebec Back Pain Disability Scale
27.9; 27.9; 15.8; 17.3
PRIMARY
10-Meter Walk Test at Self-Selected Speed (10MWT)
1.12; 1.12; 1.2; 1.21
SECONDARY
Quebec Back Pain Disability Scale
27.9; 27.9; 15.8; 17.3
SECONDARY
10 Meter Walk Test -- Self-Selected Gait Speed at 6 Months (Final Assessment)
1.12; 1.12; 1.21; 1.24
SECONDARY
10-Meter Walk Test at Fast Speed (10MWT)
1.57; 1.59; 1.65; 1.67; 1.63; 1.66
SECONDARY
Timed Up-and-Go (TUG)
9.73; 9.46; 8.92; 9.12; 8.99; 8.82
SECONDARY
Six-Minute Walk Test (6MWT)
451.0; 451.9; 489.0; 468.2; 487.8; 477.9
SECONDARY
30 Second Chair Stand Test
10; 10; 11; 11; 12; 11
SECONDARY
Movement-evoked Pain From the 6MWT and the 30 Second Chair Stand Test
6.4; 6.7; 3.6; 5.2; 3.8; 4.1
SECONDARY
Patient Health Questionnaire-9 (PHQ-9)
3.3; 2.9; 2.5; 2.6; 2.4; 2.5
SECONDARY
Low Back Activity Confidence Scale (LOBACS)
70.1; 68.9; 78.4; 74.3; 76.2; 73.0
SECONDARY
Hip Disability and Osteoarthritis Outcome Score (HOOS)
67.8; 68.6; 80.6; 77.4; 80.4; 81.6
SECONDARY
Patient-Reported Outcomes Measurement Information System (PROMIS)-29
41.8; 42.1; 46.2; 44.5; 46.5; 45.3
SECONDARY
Pain Catastrophizing Scale (PCS)
11.8; 9.5; 7.1; 6.6; 5.5; 5.9
SECONDARY
Hip Strength
0.071; 0.069; 0.077; 0.069; 0.078; 0.074
SECONDARY
Quantitative Sensory Testing
4.27; 4.46; 4.59; 4.50; 4.22; 4.45

Summary

Older adults with chronic low back pain (LBP) are at a greater risk for disability, loss of independence, and lower quality of life. Experts agree that LBP is not a homogeneous condition, and treatments should differ based upon clinical presentation. Our past work indicates that all of these hip and lumbar spine impairments may contribute to worse physical function and greater disability, but the relative importance of each impairment is unclear. Thus, clinicians have limited evidence to draw on for treatment decisions for this patient population. We have identified a vulnerable subgroup of older adults with hip and low back pain. The purpose of this study is to randomize participants into one of two treatment arms and analyze the outcomes.

Eligibility Criteria

Inclusion Criteria

  • LBP duration ≥ 3 months
  • LBP an ongoing problem for at least half days in past 6 months
  • LBP intensity > 3 on scale of 0 (no pain) to 10 (worst pain imaginable)
  • Classified into the "weak+painful" hip-spine subgroup based on two criterion. Participants must have: 1) hip internal rotation strength (normalized to body weight) in at least one hip that is 5 (0-20 range, where higher scores indicate more pain interference with daily activities).

Exclusion Criteria

  • Previous hip fracture with surgical repair
  • Previous hip fracture without surgical repair within the past 15 years
  • Total hip replacement
  • Known spinal pathology other than osteoarthritis (e.g. recent back surgery, vertebral fractures in the past year, rheumatoid arthritis, metastases)
  • Non-ambulatory or severely impairment mobility (i.e. requires wheelchair)
  • Folstein Mini-Mental State Examination score of 10 pounds, pain that awakes or keeps one awake at night)
  • Significant pain the legs greater than the back
  • Acute illness (e.g. hospitalization within the past 3 months or current infection)
  • Inability to participate in study for the full six months for any known reason
  • Received physical therapy for low back or hip within the last 3 months
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04009837). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search